| JLABS Takes Stock of Its Experiment in Life Sciences Innovation | Bruce V. Bigelow | 10/13/17 | San Diego |
| IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout | Ben Fidler | 08/03/17 | Boston |
| Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M | Ben Fidler | 04/13/17 | New York |
| At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills | Ben Fidler | 02/27/17 | Boston |
| VC Activity in Boston Dipped in 2016; Here Are the Top 10 Deals & Exits | Jeff Bauter Engel | 01/11/17 | Boston |
| Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases | Ben Fidler | 09/14/16 | Boston |
| East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More | Ben Fidler | 03/24/16 | Boston |
| Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M | Ben Fidler | 03/23/16 | Boston |
| Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer | Ben Fidler | 09/01/15 | Boston |
| East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More | Ben Fidler | 05/29/15 | Boston |
| Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups | Ben Fidler | 04/17/15 | Boston |
| From Iceland to White House, Precision Medicine’s Promises & Hurdles | Alex Lash | 03/31/15 | National |
| East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More | Ben Fidler | 12/19/14 | Boston |
| Padlock Therapeutics Obtains $23,000,000 Series A Financing Round | VentureDeal | 12/19/14 | Boston |
| Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M | Ben Fidler | 12/18/14 | Boston |
| With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors | Ben Fidler | 10/14/14 | Boston |
| Scripps Unveils New Drug Development Arm, Signs J&J as First Partner | Bernadette Tansey | 04/15/14 | San Francisco |
